Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TAO

TROLEANDOMYCIN

Standard Dose
EQ 250MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TAO is listed in Drugs@FDA under application 050336 (NDA).

Marketing status: Discontinued Active ingredient TROLEANDOMYCIN Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor PFIZER Submission history Latest submission status date: 2000-03-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAO is listed in Drugs@FDA under application 050336 (NDA). Marketing status: Discontinued Active ingredient TROLEANDOMYCIN Form and strength CAPSULE;ORAL - EQ 250MG BASE Sponsor PFIZER Submission history Latest submission status date: 2000-03-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.